Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins

Summary Context  First‐line therapy for thyrotropin‐secreting pituitary adenomas (TSHomas) is neurosurgery, while medical treatment rests mainly on somatostatin analogues. Clinically available sst2‐preferring analogues, octreotide and lanreotide, induce normalization of hormone levels in approximate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical endocrinology (Oxford) 2012-03, Vol.76 (3), p.407-414
Hauptverfasser: Gatto, Federico, Barbieri, Federica, Gatti, Monica, Wurth, Roberto, Schulz, Stefan, Ravetti, Jean-Louis, Zona, Gianluigi, Culler, Michael D., Saveanu, Alexandru, Giusti, Massimo, Minuto, Francesco, Hofland, Leo J., Ferone, Diego, Florio, Tullio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!